Lo que hacemos con la suplementacin es asegurarnos de tener los niveles ptimos para potenciar ciertas funciones, sobre todo cuando hacemos ejercicio
Learn what foods to eat, what to avoid, and how to manage this side effect with practical tips
The two pharmaceutical leaders in this space Novo Nordisk and Eli Lilly have seen astonishing growth in sales of their GLP-1 drugs for diabetes and obesity and have struggled to keep up with demand even at premium prices
SGLT-2 inhibitors in cancer treatmentmechanisms of action and emerging new perspectives
Carolyn Jasik , MD Chief Medical Officer, Omada Health Carolyn is a board-certified physician with a career spanning health technology startups, multidisciplinary care, education, and research associateships
Beyond diabetes management, Ozempic has emerged as a promising solution for weight loss, offering new hope to those dealing with both diabetes and obesity